Why Palantir Stock Is Plunging Today

Palantir fell 4% intraday and was down as much as 6.7% as Reuters reported the U.K. government is reviewing whether to end the NHS partnership, a contract worth roughly $441 million that may come up for renewal in 2027. The stock is also facing pressure from broader AI valuation concerns, pre-CPI inflation anxiety, and risk-off positioning ahead of SpaceX's June 12 IPO. Year to date, PLTR is down 26%.

Analysis

The market is treating this as a simple contract headline, but the more important issue is a durability-of-revenue reset for PLTR’s government book. If a marquee public-sector client is even plausibly considering exit, the multiple compression is not about one deal; it is about repricing renewal risk across other sovereign accounts that have been underwriting the “sticky platform” narrative.

The second-order effect is that any perceived win in public-sector AI can now become more binary: a single political review can offset months of commercial pipeline progress. That matters because PLTR’s valuation still embeds a premium for long-duration growth, so the stock is especially sensitive to any event that extends the proving period by 12-24 months. In this tape, that also makes the name a de facto hedge fund squeeze candidate if rates or CPI print hotter, since the same factor basket is being de-rated at once.

The pressure on AI multiples also creates relative value winners in less crowded software and infrastructure names. If investors continue rotating away from consensus AI beneficiaries, companies with clearer near-term monetization and lower narrative risk should outperform, while the most promoted AI equities likely trade more on positioning than fundamentals over the next 1-4 weeks. SpaceX’s IPO is relevant less as a direct comp and more as a liquidity event that can pull speculative capital out of crowded high-beta tech.

Key Decisions for Investors

• Short PLTR into strength over the next 1-3 weeks; use a defined-risk structure such as buying 30-60 DTE puts or put spreads to express downside toward the next valuation reset. Best risk/reward is after any intraday rally on broad market strength, not into the weakness.
• Pair trade: short PLTR vs long NDAQ over 1-2 months as a cleaner expression of ‘crowded AI narrative’ versus ‘picks-and-shovels market plumbing.’ NDAQ has less headline risk and should be more resilient if volatility stays elevated.
• If holding PLTR long-term, hedge with downside protection into CPI and the IPO window; the next 5-10 trading days are the most fragile because macro and positioning are reinforcing the same move.
• Look for selective long entry in beaten-down, lower-multiple AI infrastructure names only after the CPI print clears; wait for confirmation that the factor unwind is breadth-driven rather than stock-specific before adding beta.
• Avoid chasing the SpaceX IPO catalyst as a generic tech-positive read-through; if the debut is strong, it may actually intensify capital rotation into the new issue rather than lift incumbent AI names.